Wu Mengchao | Academic Influence

Why Is Wu Mengchao Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dr. Wu Mengchao , was a Chinese surgeon and a medical scientist who specialized in hepatobiliary surgery. He was also known as the "Father of Chinese Hepatobiliary Surgery". Wu was born in Minqing County, Fuzhou, China. In 1940, he was admitted to 同济附中 , a high school affiliated to Tongji University. In 1949, he graduated from Tongji University School of Medicine in Shanghai. He was elected to the Chinese Academy of Sciences in 1991 and was awarded the State Preeminent Science and Technology Award in 2005, China's highest scientific prize, by President Hu Jintao. He was the founding director of Eastern Hepatobiliary Surgery Hospital affiliated to the Second Military Medical University in Shanghai. On January 1, 2019, Wu retired.

(See a Problem?)

Wu Mengchao's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer (2018) (451)
Mutational landscape of intrahepatic cholangiocarcinoma. (2014) (276)
Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma (2013) (176)
MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. (2013) (171)
Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells (2009) (170)
Effects of Inflammatory Factors on Mesenchymal Stem Cells and Their Role in the Promotion of Tumor Angiogenesis in Colon Cancer* (2011) (162)
Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. (2012) (153)
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management. (2016) (152)
MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. (2012) (142)
Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy (2011) (134)
Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. (2008) (128)
Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. (2013) (122)
Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells (2008) (115)
Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4 (2014) (108)
Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide (2012) (108)
Epigenetic silence of ankyrin‐repeat–containing, SH3‐domain–containing, and proline‐rich‐region– containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus–positive hepatocellular carcinoma (2010) (101)
Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma (2012) (92)
Mesenchymal Stem Cells in Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition (2012) (90)
Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma. (2015) (85)
Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma Cells (2008) (83)
Acetyl‐coenzyme A carboxylase alpha promotion of glucose‐mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients (2016) (82)
Autophagic cell death induced by 5-FU in Bax or PUMA deficient human colon cancer cell. (2010) (77)
Decreased TIP30 expression promotes tumor metastasis in lung cancer. (2009) (74)
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. (2003) (71)
OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma (2012) (69)
Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells (2011) (68)
ICAM-1–Related Noncoding RNA in Cancer Stem Cells Maintains ICAM-1 Expression in Hepatocellular Carcinoma (2015) (67)
A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers (2008) (65)
Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice. (2006) (63)
TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma. (2008) (63)
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial. (2019) (63)
Proteome analysis of hepatocellular carcinoma by laser capture microdissection (2006) (62)
OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma (2013) (62)
CpG Island Methylator Phenotype Association with Elevated Serum α-Fetoprotein Level in Hepatocellular Carcinoma (2007) (61)
CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma (2008) (58)
Effective Gene-Viral Therapy for Telomerase-Positive Cancers by Selective Replicative-Competent Adenovirus Combining with Endostatin Gene (2004) (56)
Use of MicroRNA Let-7 to Control the Replication Specificity of Oncolytic Adenovirus in Hepatocellular Carcinoma Cells (2011) (55)
Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma (2013) (55)
Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin (2014) (53)
Gene Therapy Using Adenovirus-Mediated Full-length Anti-HER-2 Antibody for HER-2 Overexpression Cancers (2006) (53)
Thirty‐kilodalton Tat‐interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma (2008) (52)
Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma (2008) (48)
Interleukin‐1β/Iinterleukin‐1 receptor‐associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis (2015) (48)
HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress (2016) (48)
Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a beclin1‐dependent way in hepatocellular carcinoma (2011) (47)
TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5‐FU (2006) (46)
Increased Safety with Preserved Antitumoral Efficacy on Hepatocellular Carcinoma with Dual-Regulated Oncolytic Adenovirus (2006) (45)
Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma. (2016) (42)
P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells (2010) (41)
Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma (2016) (40)
pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma (2015) (40)
Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells (2008) (39)
Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy. (2014) (38)
Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation. (2017) (37)
An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma (2016) (36)
Potent antitumor efficacy of an E1B 55kDa‐deficient adenovirus carrying murine endostatin in hepatocellular carcinoma (2005) (36)
Autophagy inhibition switches low-dose camptothecin-induced premature senescence to apoptosis in human colorectal cancer cells. (2014) (36)
Interferon–microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis (2016) (35)
Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma. (2010) (35)
Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. (2011) (35)
Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells (2013) (34)
Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53 (2016) (34)
Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro (2008) (32)
Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma (2015) (32)
Gene-Viral Cancer Therapy Using Dual-Regulated Oncolytic Adenovirus with Antiangiogenesis Gene for Increased Efficacy (2008) (31)
Tumor Necrosis Factor-alpha Promotes Tumor Growth by Inducing Vascular Endothelial Growth Factor (2011) (31)
5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells. (2011) (30)
Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma Cells (2007) (30)
Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. (2012) (30)
Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases (2013) (30)
Inhibitory effect of Survivin promoter‐regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer (2011) (29)
Elevated Expression of the Stem Cell Marker CD133 Associated with Line-1 Demethylation in Hepatocellular Carcinoma (2011) (29)
Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma (2016) (28)
Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system. (2012) (28)
The protective or damaging effect of Tumor necrosis factor-α in acute liver injury is concentration-dependent (2016) (28)
A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B. (2019) (27)
hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers (2011) (27)
siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma (2008) (27)
Mesenchymal stem cells contribute to the chemoresistance of hepatocellular carcinoma cells in inflammatory environment by inducing autophagy (2014) (26)
Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma (2013) (24)
Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway. (2016) (23)
Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU (2007) (23)
Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo. (2011) (21)
The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma (2012) (21)
Infusion of human umbilical cord‑derived mesenchymal stem cells effectively relieves liver cirrhosis in DEN‑induced rats. (2014) (20)
Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection (2011) (20)
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer (2015) (20)
LPS-induced CXCR4-dependent migratory properties and a mesenchymal-like phenotype of colorectal cancer cells (2017) (20)
Meta-analysis of laparoscopic versus open liver resection for colorectal liver metastases (2016) (20)
Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma (2014) (19)
Establishment of a novel system for the culture and expansion of hepatic stem-like cancer cells. (2015) (19)
Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk (2015) (19)
Inhibition of tumorigenesis and invasion of hepatocellular carcinoma by siRNA-mediated silencing of the livin gene. (2010) (18)
Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates. (2008) (18)
Dual regulation of HMGB1 by combined JNK1/2–ATF2 axis with miR‐200 family in nonalcoholic steatohepatitis in mice (2018) (18)
TIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathway. (2005) (17)
Autophagy regulates biliary differentiation of hepatic progenitor cells through Notch1 signaling pathway (2016) (17)
Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model (2014) (17)
The Injured Liver Induces Hyperimmunoglobulinemia by Failing to Dispose of Antigens and Endotoxins in the Portal System (2015) (15)
Transfection of IL-2 and/or IL-12 genes into spleen in treatment of rat liver cancer. (2004) (15)
Methylation‐Related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma (2008) (15)
Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest. (2015) (15)
Lipopolysaccharide promotes tumorigenicity of hepatic progenitor cells by promoting proliferation and blocking normal differentiation. (2017) (15)
Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma (2016) (14)
Up-regulation of hTERT expression by low-dose cisplatin contributes to chemotherapy resistance in human hepatocellular cancer cells. (2009) (14)
Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously. (2002) (12)
Tumor necrosis factor-α attenuates starvation-induced apoptosis through upregulation of ferritin heavy chain in hepatocellular carcinoma cells (2013) (12)
Human sulfatase‐1 inhibits the migration and proliferation of SMMC‐7721 hepatocellular carcinoma cells by downregulating the growth factor signaling (2013) (12)
mda-7/IL-24 induces apoptosis in human HepG2 hepatoma cells by endoplasmic reticulum stress. (2008) (11)
High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma (2019) (11)
A Rare Case of Rapid Growth of Exophytic Gastrointestinal Stromal Tumor of the Stomach (2005) (11)
[Correlation between midkine protein overexpression and intrahepatic metastasis in hepatocellular carcinoma]. (2002) (10)
Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis (2018) (10)
Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma. (2006) (10)
Does microvascular invasion in Barcelona Clinic Liver Cancer stage A multinodular hepatocellular carcinoma indicate early-stage behavior? (2019) (10)
Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma. (2012) (9)
The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma. (2020) (9)
Potent antitumoral effects of a novel gene-viral therapeutic system CNHK300-mEndostatin in hepatocellular carcinoma. (2005) (9)
Characterization of Two Novel Cell Lines with Distinct Heterogeneity Derived from a Single Human Bile Duct Carcinoma (2013) (9)
Establishment of Mouse Teratocarcinomas Stem Cells Line and Screening Genes Responsible for Malignancy (2012) (8)
Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma (2020) (8)
Post-operative delayed elevation of ALT correlates with early death in patients with HBV-related hepatocellular carcinoma and Post-hepatectomy Liver Failure. (2018) (8)
[Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene]. (2004) (8)
Conversion of rat embryonic stem cells into neural precursors in chemical-defined medium. (2013) (8)
In situ detection of tumor infiltrating lymphocytes expressing perforin and fas ligand genes in human HCC. (1999) (7)
[Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin]. (2004) (7)
"Wrapping the gastroduodenal artery stump" during pancreatoduodenectomy reduced the stump hemorrhage incidence after operation. (2014) (7)
Germ-line-competent embryonic stem cells of the Chinese Kunming mouse strain with long-term self-renewal ability. (2013) (6)
Generation of adenovirus-mediated anti-CD20 antibody and its effect on B-cell deletion in mice and nonhuman primate cynomolgus monkey (2008) (6)
TIP 30 Induces Apoptosis under Oxidative Stress through Stabilization of p 53 Messenger RNA in Human Hepatocellular Carcinoma (2008) (6)
Expression of perforin and granzyme B mRNA in judgement of immunosuppressive effect in rat liver transplantation. (1999) (6)
[Establishment and characterization of a human gallbladder carcinoma cell line EH-GB1 originated from a metastatic tumor]. (2010) (5)
Prognostic analysis of radical resection for intrahepatic cholangiocarcinoma: a retrospective cohort study. (2017) (4)
Wnt/beta-catenin signaling in embryonic stem cell converted tumor cells (2012) (4)
Prognostic analysis of radical resection for intrahepatic cholangiocarcinoma: a retrospective cohort study (2017) (4)
CCL20 is overexpressed in hepatocellular carcinoma with bile duct tumor thrombus and correlates negatively with surgical outcome. (2018) (4)
[Effective ways to improve the prognosis of advanced stage (BCLC stage C) hepatocellular carcinoma]. (2015) (4)
Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma (2019) (4)
Relationship between the imaging features and pathologic alteration in hepatoma of rats. (2003) (4)
[The specific cytotoxic effect of tumor infiltrating lymphocytes transfected with chimeric T cell receptor on cells which express KDR]. (2004) (3)
Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP. (2021) (3)
An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection. (2009) (3)
Successful en bloc resection of recurrent hepatocellular carcinoma directly invading the abdominal wall: a case report (2015) (3)
Regulation of Bcl-2 Family in TIP30-Induced Apoptosis in Hepatoblastoma Cells (2005) (2)
Clinical significance of telomerase activity and human telomerase reverse transcriptase mRNA expression for differential diagnosis of malignant and benign liver lesions (2004) (2)
[Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study]. (2003) (2)
[Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer]. (2002) (2)
Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA (2016) (2)
[CNHK200-hA-a gene-viral therapeutic system and its antitumor effect on lung cancer]. (2005) (1)
An Arti fi cially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Ef fi cacy in Hepatocellular Carcinoma (2016) (1)
[Effect of antiviral treatment on improving postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma]. (2015) (1)
[The in vivo antitumor activity of murine liver tumor vaccine expressing MIP-1alpha]. (2002) (1)
Profiles of a Novel p 53-Armed Replication-Competent Oncolytic Adenovirus in Rodents , Felids , and Nonhuman Primates (2008) (1)
[In vitro gene therapy of hepatocellular carcinoma using replication-defective and tumor-specific replication-competent adenovirus carrying interleukin-12 gene]. (2004) (1)
Effect of miR-21 on the proliferation and migration of human hepatoma BEL-7402 cells through AKT/ERK pathway (2013) (1)
The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma (2020) (0)
Correction (2014) (0)
Treatment of rat hepatoma by locally injection of murine IL-12 retrovirus packaging cell (2000) (0)
[Injection of NKG5SV gene to inhibit growth and metastasis of hepatocellular carcinoma]. (2002) (0)
miR-369-3p serves as prognostic factor and regulates cancer progression of hepatocellular carcinoma. (2021) (0)
[Corrigendum] Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest (2015) (0)
Germline Transmission of an Embryonic Stem Cell Line Derived from BALB/c Cataract Mice (2014) (0)
Title : Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines (2011) (0)
Tumorigenesis and Neoplastic Progression Decreased TIP 30 Expression Promotes Tumor Metastasis in Lung Cancer (2010) (0)
Correlation between midkine protein overexpression in hepatocellular carcinoma with the presence of tumor cells in circulating blood (2004) (0)
Experimental study on double blocking of T lymphocytes apoptosis induced by Fas/FasL (2006) (0)
Publisher Correction: Precancer antiviral treatment reduces microvascular invasion of early-stage Hepatitis B-related hepatocellular carcinoma (2019) (0)
[Development of gene-viral vector and its anti-tumor effect, a primary study]. (2002) (0)
253 SIRNA TARGETING HEPATITIS B VIRUS X AND AZA-C INHIBIT GROWTH OF HEPATOCELLULAR CARCINOMA CELLS VIA INDUCTION OF G0/G1 ARREST DUE TO REVERSE P16 HYPERMETHYLATION (2009) (0)
Expression of differentiation inhibitory factor and prognosis of malignant tumors: Expression of differentiation inhibitory factor and prognosis of malignant tumors (2010) (0)
Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Cancer Letters 337 (2013) 226-236]. (2020) (0)
Effect of tissue microenvironment on development and progression of cancer: Effect of tissue microenvironment on development and progression of cancer (2009) (0)
TRAIL and its receptor expression in activated lymphocytes (2002) (0)
Enhancement of T cell activity by transfecting IL-2 and/or IL-12 genes into spleen in implanted liver cancer rats (2004) (0)
591 HEPATITIS B VIRUS X PROMOTES CELL CYCLE PROGRESSION IN HEPATOCELLULAR CARCINOMA CELL VIA INDUCTION OF P16INK4A METHYLATION AND REPRESSING P16 EXPRESSION (2009) (0)
TNF-α induces epithelial-mesenchymal transition through NF-κB in hepatocellular carcinoma: TNF-α induces epithelial-mesenchymal transition through NF-κB in hepatocellular carcinoma (2013) (0)
[Hypoxia augments the killing effect of herpes simplex virus thymidine kinase gene expression actuated by the promoter of the vascular endothelial growth factor gene on human hepatocellular tumor cells]. (2002) (0)
Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236]. (2020) (0)
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]. (2003) (0)
A Novel Replication-competent Adenovirus CNHK500 in the Treatment of Heptocellular Carcinoma In Vitro (2004) (0)
[Antitumor immunity elicited by 4-1BBL gene transfected Hepa1-6 in vivo]. (2002) (0)
Association of alpha fetoprotein in hepatocellular carcinoma with activation of hepatic progenitor cells and patient prognosis: Association of alpha fetoprotein in hepatocellular carcinoma with activation of hepatic progenitor cells and patient prognosis (2012) (0)
Biological characteristics and regulatory mechanisms of hepatic progenitor cells: recent progress: Biological characteristics and regulatory mechanisms of hepatic progenitor cells: recent progress (2013) (0)

This paper list is powered by the following services:

Other Resources About Wu Mengchao

en.wikipedia.org

What Schools Are Affiliated With Wu Mengchao?

Wu Mengchao is affiliated with the following schools:

Wu Mengchao's AcademicInfluence.com Rankings